𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent

✍ Scribed by Andrew H. Murr; Timothy L. Smith; Peter H. Hwang; Neil Bhattacharyya; Brent J. Lanier; James W. Stambaugh; Andrew S. Mugglin

Publisher
Wiley (John Wiley & Sons)
Year
2011
Tongue
English
Weight
478 KB
Volume
1
Category
Article
ISSN
2042-6976

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

ADVANCE: A multisite trial of bioabsorba
ADVANCE: A multisite trial of bioabsorbable steroid-eluting sinus implants
✍ Keith D. Forwith; Rakesh K. Chandra; Paul T. Yun; Steven K. Miller; Henry D. Jam πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 287 KB

## Abstract ## Objectives/Hypothesis: Disease recurrence and adverse wound healing in the form of inflammation, polyposis, adhesions, and middle turbinate lateralization may induce suboptimal outcomes following sinus surgery. The study objective was to assess the safety and effectiveness of a bioa

A novel bioabsorbable drug-eluting trach
A novel bioabsorbable drug-eluting tracheal stent
✍ G. H. Zhu; Anthony H. C. Ng; Subbu S. Venkatraman; Freddy Y. C. Boey; Amilia L. πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 205 KB

## Abstract ## Objectives/Hypothesis: Currently available silicone and metallic stents for tracheal stenosis are associated with problems of granulations, mucus trapping, and difficult removals. Our aim was to develop a novel bioabsorbable tracheal stent with mitomycin C (MMC) drug elution to circ

Real world safety and efficacy of the Ja
Real world safety and efficacy of the Janus tacrolimus-eluting stent: Long-term clinical outcome and angiographic findings from the tacrolimus-eluting stent (TEST) registry
✍ Corrado Tamburino; Maria Elena Di Salvo; Davide Capodanno; Piera Capranzano; Ros πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 2 views

## Abstract ## Objectives: We sought to evaluate the safety and performance of the Janus Tacrolimus‐Eluting stent (TES) in an unselected population of patients, without application of restrictive clinical or angiographic criteria. ## Background: Continued attention to the safety, efficacy, and d